Cross-sectional Study on Medical Attitude Towards Artificial Intelligence Use in Fibromyalgia: Insights From the Annual Thinking Lab on Fibromyalgia Syndrome (ATLAS 2024).

Background: The integration of artificial intelligence (AI) in healthcare has the potential to revolutionize clinical practice, particularly in the management of complex conditions such as fibromyalgia (FM). Despite its promise, the adoption of this technology in practice faces several challenges, including limited knowledge and preparedness among healthcare professionals.

Aim: To evaluate the level of knowledge before and after a workshop on AI in FM among clinicians of different disciplines.

Methods: A survey was conducted at the end of the lab. An anonymous 21-item questionnaire was administered to participants.

Results: This survey (n = 26) revealed that while most had extensive clinical experience and some prior exposure to AI, the majority lacked sufficient knowledge and felt unprepared to integrate AI into FM management. Post-congress, perceptions of AI improved for many, but significant barriers remained, including lack of training, resistance to change, and cost concerns. Key benefits identified were symptom monitoring and decision support. Targeted training and technical support were highlighted as essential for effective AI adoption in clinical practice.

Conclusion: Despite a generally positive shift in perception following the congress, many doctors still feel unprepared and lack the necessary knowledge to effectively utilize AI tools. These results underscore the importance of targeted training and support to implement research and facilitate the integration of AI tools in FM and other clinical settings.